Key result
Elevated triglyceride-glucose index linked to ~38% higher all-cause mortality risk.
Why the study?
The impact of the triglyceride-glucose (TyG) index on mortality in patients with diabetes and hypertension remains unclear.
Is the triglyceride-glucose (TyG) index associated with all-cause and cardiovascular mortality in patients with diabetes mellitus and hypertension?
Cohort (n=3,296)
Yes
Is the triglyceride-glucose (TyG) index associated with all-cause and cardiovascular mortality in patients with diabetes mellitus and hypertension?
In patients with diabetes and hypertension, a TyG index above 8.9 is associated with increased all-cause mortality, and above 9.0 with increased cardiovascular mortality, particularly in those under 65 years old.
Answers are grounded in this paper and cite their sources.
TyG index >8.9 was associated with higher mortality; leaves open its added value for risk stratification in diabetes with hypertension.
Background The impact of the triglyceride–glucose (TyG) index on mortality in diabetes patients with hypertension remains unclear. Methods This retrospective cohort study included 3296 participants from the National Health and Nutrition Examination Survey (2001–2018). The TyG index was calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. Multivariable Cox proportional hazards models adjusted for demographic and clinical confounders were used to estimate mortality risks. Restricted cubic spline analysis assessed nonlinear relationships between TyG index and mortality risk. Stratified analyses and interaction tests were conducted based on gender, age, race, body mass index, smoking status, and the presence of cardiovascular disease. Results A total of 3296 individuals were ultimately included in the study cohort. Over a median follow‐up of 82 months (IQR, 44–129), 912 participants (27.7%) died, with 315 (9.6%) from cardiovascular disease. A nonlinear association between TyG index and mortality was observed, with inflection points at 8.9 for all‐cause mortality and 9.0 for cardiovascular mortality. Hazard ratios (95% CI) were 0.85 (0.62–1.16) and 1.38 (1.14–1.67) for all‐cause mortality and 0.70 (0.44–1.01) and 1.78 (1.27–2.48) for cardiovascular mortality, below and above these points, respectively. In participants aged < 65 years, elevated TyG index levels showed significantly greater susceptibility to all‐cause mortality [HR = 1.69 (1.20–2.39), p < 0.003, interaction p = 0.01]. Conclusion In this national cohort of adults with diabetes and hypertension, the TyG index showed a nonlinear association with mortality: the risk of all‐cause death increased above TyG = 8.9 and cardiovascular death above TyG = 9.0; associations were stronger among participants under 65 years old.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cohort in Diabetes Mellitus with Hypertension (n=3,296). Triglyceride-glucose (TyG) index vs. TyG index below inflection points (8.9 for all-cause, 9.0 for CV mortality) was evaluated on All-cause mortality (HR 1.38, 95% CI 1.14-1.67). The triglyceride-glucose index showed a nonlinear association with mortality, with the risk of all-cause death increasing above an index of 8.9.
Synapse has enriched 10 related papers. Consider them for comparative context: